In contrast to the suspected connection between increased platelet activation and an increase of vascular events, Riedl et al. have shown that a diminished P-selectin and GPIIb/IIIa expression on platelets was associated with a higher risk of DVT in a mixed cohort of cancer patients from different sides [27]. Here, ITGA2B is linked to cancer.